Stemina Biomarker Discovery, Inc.

Madison,  WI 
United States
  • Booth: 1730

Compound safety screening to improve human health

Stemina has pioneered development of all human, cell-based tests to screen compounds for their potential to cause birth defects or cardiotoxicity. Our devTOX quickPredict assay is highly predictive of developmental toxicity, as shown in a joint US EPA study published in Toxicological Sciences, and is the only commercially available human-based screen. Our Cardio quickPredict assay assesses structural and functional cardiotoxicity with high accuracy, as published in Toxicological Sciences.

Send Email

Type your information and click "Send Email" to send an email to this exhibitor. To return to the previous screen without saving, click "Reset".